红海藻衍生化合物:一种治疗癌症的理想方法
Shweta Katiyar1, Xing-Hai Jin2, Dhananjay Yadav3
1Department of Botany, SBN Government PG College, Barwani (M.P), India.
Current pharmaceutical design
|July 31, 2023
概括
红色大藻产生的生物活性化合物具有显著的抗癌特性,为传统的癌症治疗提供了有希望的替代方案,并克服了耐药性. 这项研究探讨了它们对抗关键癌症点的潜力.
科学领域:
- 海洋生物学 海洋生物学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- 癌症涉及不受控制的细胞生长,对化疗,放射治疗和手术的耐药性是一个主要的挑战.
- 大藻,特别是红藻,是富含生物活性化合物的来源,如多糖和化合物.
- 这些化合物表现出抗微生物,抗氧化,抗炎和抗癌的特性,这表明在癌症治疗中的潜力.
研究的目的:
- 审查红色藻在癌症治疗中的治疗潜力.
- 为了识别抗癌有效的红藻生物活性化合物和提取物.
- 讨论红藻衍生物化合物易受癌症的主要治疗点.
主要方法:
- 对红色大藻和癌症治疗研究的文献综述.
- 对生物活性化合物 (多糖,等) 的分析. 来自红藻类的红藻.
- 识别癌症标和相应的红藻衍生分子.
主要成果:
- 红藻含有多种生物活性化合物,具有已证明的抗癌活性.
- 特定的化合物和提取物显示对各种癌症类型和点的疗效.
- 来自海洋的分子为新型癌症疗法提供了可行的途径.
结论:
- 红色藻是开发新的抗癌剂的宝贵资源.
- 对红藻化合物的进一步研究可能会导致创新的癌症治疗策略.
- 红藻中的生物活性分子在克服癌症药物耐药性方面表现有前途.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


